Oragenics, Inc.
4902 Eisenhower Boulevard, Suite
Tampa, Florida 33634
July 11, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare and Insurance
100 F Street, N.E.
Washington, D.C. 20549-3628
Attn: Ms. Dorrie Yale
| Re: | Oragenics, Inc. (the “Company”) |
Registration Statement on FormS-1
FileNo. 333-224950
Request for Acceleration
Dear Ms. Yale:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above referenced Registration Statement on FormS-1 be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time, on Thursday July 12, 2018, or as soon thereafter as is practicable.
Please call Mark Catchur, of Shumaker, Loop & Kendrick, LLP counsel to the Registrant, at (813)227-2264 with any comments or questions regarding this matter.
| Very truly yours, | ||
By: | /s/ Michael Sullivan | |
Name: Michael Sullivan | ||
Title: Chief Financial Officer | ||
| cc: | Mark A. Catchur, Shumaker, Loop & Kendrick, LLP |